Lotte Steuten

4.1k total citations · 1 hit paper
117 papers, 2.6k citations indexed

About

Lotte Steuten is a scholar working on Economics and Econometrics, Epidemiology and General Health Professions. According to data from OpenAlex, Lotte Steuten has authored 117 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Economics and Econometrics, 28 papers in Epidemiology and 22 papers in General Health Professions. Recurrent topics in Lotte Steuten's work include Health Systems, Economic Evaluations, Quality of Life (57 papers), Chronic Disease Management Strategies (16 papers) and Economic and Financial Impacts of Cancer (10 papers). Lotte Steuten is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (57 papers), Chronic Disease Management Strategies (16 papers) and Economic and Financial Impacts of Cancer (10 papers). Lotte Steuten collaborates with scholars based in Netherlands, United States and United Kingdom. Lotte Steuten's co-authors include Hubertus JM Vrijhoef, Maarten J. IJzerman, Janne C. Mewes, Wim H. van Harten, Valesca P. Retèl, Cor Spreeuwenberg, Eva C. Creutzberg, Emiel F.�M. Wouters, Martin Buxton and Karin Lemmens and has published in prestigious journals such as JAMA, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Lotte Steuten

109 papers receiving 2.5k citations

Hit Papers

Delivering precision oncology to patients with cancer 2022 2026 2023 2024 2022 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Delivering precision oncology to patients with cancer
    2022 197 citations Joaquı́n Mateo, Lotte Steuten et al. Nature Medicine profile →

Peers

Lotte Steuten
Hendrik Koffijberg Netherlands
Javier Mar Spain
Nancy A Dreyer United States
Scott D. Ramsey United States
Maiwenn Al Netherlands
Raoh‐Fang Pwu Taiwan
Takeru Shiroiwa Japan
Feng Xie Canada
A Bagust United Kingdom
Joke C. Korevaar Netherlands
Hendrik Koffijberg Netherlands
Lotte Steuten
Citations per year, relative to Lotte Steuten Lotte Steuten (= 1×) peers Hendrik Koffijberg

Countries citing papers authored by Lotte Steuten

Since Specialization
Citations

This map shows the geographic impact of Lotte Steuten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lotte Steuten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lotte Steuten more than expected).

Fields of papers citing papers by Lotte Steuten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lotte Steuten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lotte Steuten. The network helps show where Lotte Steuten may publish in the future.

Co-authorship network of co-authors of Lotte Steuten

This figure shows the co-authorship network connecting the top 25 collaborators of Lotte Steuten. A scholar is included among the top collaborators of Lotte Steuten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lotte Steuten. Lotte Steuten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cole, Amanda, et al.. (2025). Alternative Payment Models for Innovative Medicines: A Framework for Effective Implementation. Applied Health Economics and Health Policy. 23(4). 535–549. 1 indexed citations
2.
Su, Christopher, Wael Saber, Aasthaa Bansal, et al.. (2025). Out-of-Pocket Expenditures and Financial Hardship Among Patients With Myelodysplastic Syndrome Undergoing Allogeneic Transplant or Hypomethylating Agent / Supportive Care (BMT CTN 1102). Transplantation and Cellular Therapy. 31(7). 459.e1–459.e6. 1 indexed citations
3.
Kumar, Gayathri S., Amanda Cole, Lieven Annemans, et al.. (2024). Evolving assessment pathways for precision oncology medicines to improve patient access: a tumor-agnostic lens. The Oncologist. 29(6). 465–472.
4.
Saber, Wael, Aasthaa Bansal, Bart L. Scott, et al.. (2024). Cost-Effectiveness of Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Older Patients With High-Risk Myelodysplastic Syndrome: Analysis of BMT CTN 1102. JCO Oncology Practice. 20(4). 572–580. 6 indexed citations
5.
Mendes, Diana, et al.. (2023). PP10 Preventing The Winter Quadruple Threat: The Value Of Hospital Bed Capacity Freed Up By Vaccination. International Journal of Technology Assessment in Health Care. 39(S1). S54–S54. 1 indexed citations
6.
Akkooi, Alexander C. J. van, et al.. (2023). Adjuvant immune checkpoint blockade revisited; the need to consider more factors and involve all stakeholders. SHILAP Revista de lepidopterología. 2. 100014–100014.
7.
Ramsey, Scott D., Aasthaa Bansal, Paul V. O’Donnell, et al.. (2023). Cost-Effectiveness of Unrelated Umbilical Cord Blood Transplantation versus HLA-Haploidentical Related Bone Marrow Transplantation: Evidence from BMT CTN 1101. Transplantation and Cellular Therapy. 29(7). 464.e1–464.e8. 4 indexed citations
8.
Fusco, Manuela Di, Diana Mendes, Lotte Steuten, et al.. (2023). The Societal Value of Vaccines: Expert-Based Conceptual Framework and Methods Using COVID-19 Vaccines as a Case Study. Vaccines. 11(2). 234–234. 7 indexed citations
9.
Steuten, Lotte, et al.. (2023). Value assessment of antimicrobials using the STEDI framework – How steady is the outcome?. Health Policy. 136. 104892–104892. 2 indexed citations
10.
Mateo, Joaquı́n, Lotte Steuten, Philippe Aftimos, et al.. (2022). Delivering precision oncology to patients with cancer. Nature Medicine. 28(4). 658–665. 197 indexed citations breakdown →
11.
Towse, Adrian, et al.. (2022). Working towards a sustainable, healthy market for vaccines: A framework to support evidence-based policymaking. Vaccine. 40(29). 3919–3922. 1 indexed citations
12.
Bell, E. J., et al.. (2021). Towards a Broader Assessment of Value in Vaccines: The BRAVE Way Forward. Applied Health Economics and Health Policy. 20(1). 105–117. 33 indexed citations
13.
14.
Steuten, Lotte, et al.. (2019). Treatment Patterns, Overall Survival, and Total Healthcare Costs of Advanced Merkel Cell Carcinoma in the USA. Applied Health Economics and Health Policy. 17(5). 733–740. 10 indexed citations
15.
Mewes, Janne C., et al.. (2019). Cost-Effectiveness Analysis of a Procalcitonin-Guided Decision Algorithm for Antibiotic Stewardship Using Real-World U.S. Hospital Data. OMICS A Journal of Integrative Biology. 23(10). 508–515. 41 indexed citations
16.
17.
Mewes, Janne C., Lotte Steuten, Saskia F. A. Duijts, et al.. (2013). Cost-Effectiveness Of Cognitive-Behavioral Therapy And Physical Exercise For Alleviating Treatment-Induced Menopausal Symptoms In Breast Cancer Patients. Value in Health. 16(3). A141–A141. 2 indexed citations
18.
Meeuwissen, Jolanda A. C., Lidwien Lemmens, Hanneke W. Drewes, et al.. (2012). Meta-analysis and meta-regression analyses explaining heterogeneity in outcomes of chronic care management for depression: implications for person-centered mental healthcare. 2(4). 716–758. 12 indexed citations
19.
Lemmens, Lidwien, Hanneke W. Drewes, Arianne Elissen, et al.. (2012). Meta-analysis and meta-regression analyses explaining heterogeneity in outcomes of chronic care management for depression. Research portal (Tilburg University). 2(4).
20.
Steuten, Lotte, Stephen Palmer, Hubertus JM Vrijhoef, et al.. (2007). Cost-utility of a disease management program for patients with asthma. International Journal of Technology Assessment in Health Care. 23(2). 184–191. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hendrik Koffijberg Breakdown of academic impact, for papers by Javier Mar Breakdown of academic impact, for papers by Nancy A Dreyer Breakdown of academic impact, for papers by Scott D. Ramsey Breakdown of academic impact, for papers by Maiwenn Al Breakdown of academic impact, for papers by Raoh‐Fang Pwu Breakdown of academic impact, for papers by Takeru Shiroiwa Breakdown of academic impact, for papers by Feng Xie Breakdown of academic impact, for papers by A Bagust Breakdown of academic impact, for papers by Joke C. Korevaar
Rankless by CCL
2026